MeCP2 Dysfunction in Decidual Stromal Cells is Related to Dysregulation of Decidualization

Abstract Objective: To investigate the role of decidual methyl-CpG-binding protein 2 ( MeCP2 ) expression in the pathogenesis of preeclampsia by comparing preeclamptic patients with normotensive pregnant controls, and to elucidate the underlying mechanisms through which this epigenetic regulator exerts its effects. Methods: Differentially expressed genes in the decidua of patients with preeclampsia were analyzed using single-cell sequencing. Target molecule expression was validated using western blotting, qPCR, and immunohistochemistry. Furthermore, the expression levels of DNA methyltransferase-related genes and decidualization markers were examined, and DNA 5-hydroxymethylcytosine (5-hmC) methylation levels were detected by enzyme-linked immunosorbent assay. To investigate the roles of decidualization and MeCP2 in preeclampsia, an in vitro model using human endometrial stromal cells (hESCs) was established. Decidualization was then induced, and MeCP2 was knocked down and the effects assessed. RNA sequencing was also used to analyze the effect of MeCP2 in hESCs. Results: MeCP2 expression was decreased in the decidua of patients with preeclampsia, accompanied by features indicative of decidualization defects. Aberrant DNA methylation levels, along with altered expression of DNA methyltransferase-related genes, were observed in the pre-eclamptic decidua, alongside an upregulation of DNA 5-hmC methylation levels. These findings suggest that an association exists between aberrant DNA methylation and impaired decidualization in preeclampsia. Further investigation revealed that the knockdown of MeCP2 in human endometrial stromal cells (hESCs) resulted in reduced decidualization capacity. Conclusion: In the preclamptic decidua, decreased expression of MeCP2 and aberrant DNA methylation are associated with defects in decidualization. Using an in vitro ESC model, MeCP2 was found to be associated with the decidualization process, wherein its knockdown resulted in characteristics of decidualization impairment.

Authors

Institutions

Publication Details

Journal
Maternal-Fetal Medicine
Published
2026-09-10
DOI
https://doi.org/10.1097/fm9.0000000000000379
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

MeCP2 Dysfunction in Decidual Stromal Cells is Related to Dysregulation of Decidualization

Minshan Huang, Dunjin Chen, Jingsi Chen, Lijun Huang
Maternal-Fetal Medicine
Pregnancy and preeclampsia studies
article

MeCP2 Dysfunction in Decidual Stromal Cells is Related to Dysregulation of Decidualization

Minshan Huang, Dunjin Chen, Jingsi Chen, Lijun Huang
article en

Abstract

Abstract Objective: To investigate the role of decidual methyl-CpG-binding protein 2 ( MeCP2 ) expression in the pathogenesis of preeclampsia by comparing preeclamptic patients with normotensive pregnant controls, and to elucidate the underlying mechanisms through which this epigenetic regulator exerts its effects. Methods: Differentially expressed genes in the decidua of patients with preeclampsia were analyzed using single-cell sequencing. Target molecule expression was validated using western blotting, qPCR, and immunohistochemistry. Furthermore, the expression levels of DNA methyltransferase-related genes and decidualization markers were examined, and DNA 5-hydroxymethylcytosine (5-hmC) methylation levels were detected by enzyme-linked immunosorbent assay. To investigate the roles of decidualization and MeCP2 in preeclampsia, an in vitro model using human endometrial stromal cells (hESCs) was established. Decidualization was then induced, and MeCP2 was knocked down and the effects assessed. RNA sequencing was also used to analyze the effect of MeCP2 in hESCs. Results: MeCP2 expression was decreased in the decidua of patients with preeclampsia, accompanied by features indicative of decidualization defects. Aberrant DNA methylation levels, along with altered expression of DNA methyltransferase-related genes, were observed in the pre-eclamptic decidua, alongside an upregulation of DNA 5-hmC methylation levels. These findings suggest that an association exists between aberrant DNA methylation and impaired decidualization in preeclampsia. Further investigation revealed that the knockdown of MeCP2 in human endometrial stromal cells (hESCs) resulted in reduced decidualization capacity. Conclusion: In the preclamptic decidua, decreased expression of MeCP2 and aberrant DNA methylation are associated with defects in decidualization. Using an in vitro ESC model, MeCP2 was found to be associated with the decidualization process, wherein its knockdown resulted in characteristics of decidualization impairment.

Maternal-Fetal Medicine
Third Affiliated Hospital of Guangzhou Medical University (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 8%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.